Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization.

IF 6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Circulation: Genomic and Precision Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-21 DOI:10.1161/CIRCGEN.123.004272
Johanna L Smith, Catherine Tcheandjieu, Ozan Dikilitas, Kruthika Iyer, Kazuo Miyazawa, Austin Hilliard, Julie Lynch, Jerome I Rotter, Yii-Der Ida Chen, Wayne Huey-Herng Sheu, Kyong-Mi Chang, Stavroula Kanoni, Philip S Tsao, Kaoru Ito, Matthew Kosel, Shoa L Clarke, Daniel J Schaid, Themistocles L Assimes, Iftikhar J Kullo
{"title":"Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization.","authors":"Johanna L Smith, Catherine Tcheandjieu, Ozan Dikilitas, Kruthika Iyer, Kazuo Miyazawa, Austin Hilliard, Julie Lynch, Jerome I Rotter, Yii-Der Ida Chen, Wayne Huey-Herng Sheu, Kyong-Mi Chang, Stavroula Kanoni, Philip S Tsao, Kaoru Ito, Matthew Kosel, Shoa L Clarke, Daniel J Schaid, Themistocles L Assimes, Iftikhar J Kullo","doi":"10.1161/CIRCGEN.123.004272","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Predictive performance of polygenic risk scores (PRS) varies across populations. To facilitate equitable clinical use, we developed PRS for coronary heart disease (CHD; PRS<sub>CHD</sub>) for 5 genetic ancestry groups.</p><p><strong>Methods: </strong>We derived ancestry-specific and multi-ancestry PRS<sub>CHD</sub> based on pruning and thresholding (PRS<sub>PT</sub>) and ancestry-based continuous shrinkage priors (PRS<sub>CSx</sub>) applied to summary statistics from the largest multi-ancestry genome-wide association study meta-analysis for CHD to date, including 1.1 million participants from 5 major genetic ancestry groups. Following training and optimization in the Million Veteran Program, we evaluated the best-performing PRS<sub>CHD</sub> in 176,988 individuals across 9 diverse cohorts.</p><p><strong>Results: </strong>Multi-ancestry PRS<sub>PT</sub> and PRS<sub>CSx</sub> outperformed ancestry-specific PRS<sub>PT</sub> and PRS<sub>CSx</sub> across a range of tuning values. Two best-performing multi-ancestry PRS<sub>CHD</sub> (ie, PRS<sub>PTmult</sub> and PRS<sub>CSxmult</sub>) and 1 ancestry-specific (PRS<sub>CSxEUR</sub>) were taken forward for validation. PRS<sub>PTmult</sub> demonstrated the strongest association with CHD in individuals of South Asian ancestry and European ancestry (odds ratio per 1 SD [95% CI, 2.75 [2.41-3.14], 1.65 [1.59-1.72]), followed by East Asian ancestry (1.56 [1.50-1.61]), Hispanic/Latino ancestry (1.38 [1.24-1.54]), and African ancestry (1.16 [1.11-1.21]). PRS<sub>CSxmult</sub> showed the strongest associations in South Asian ancestry (2.67 [2.38-3.00]) and European ancestry (1.65 [1.59-1.71]), lower in East Asian ancestry (1.59 [1.54-1.64]), Hispanic/Latino ancestry (1.51 [1.35-1.69]), and the lowest in African ancestry (1.20 [1.15-1.26]).</p><p><strong>Conclusions: </strong>The use of summary statistics from a large multi-ancestry genome-wide meta-analysis improved the performance of PRS<sub>CHD</sub> in most ancestry groups compared with single-ancestry methods. Despite the use of one of the largest and most diverse sets of training and validation cohorts to date, improvement of predictive performance was limited in African ancestry. This highlights the need for larger genome-wide association study datasets of underrepresented populations to enhance the performance of PRS<sub>CHD</sub>.</p>","PeriodicalId":10326,"journal":{"name":"Circulation: Genomic and Precision Medicine","volume":" ","pages":"e004272"},"PeriodicalIF":6.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11372723/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Genomic and Precision Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCGEN.123.004272","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Predictive performance of polygenic risk scores (PRS) varies across populations. To facilitate equitable clinical use, we developed PRS for coronary heart disease (CHD; PRSCHD) for 5 genetic ancestry groups.

Methods: We derived ancestry-specific and multi-ancestry PRSCHD based on pruning and thresholding (PRSPT) and ancestry-based continuous shrinkage priors (PRSCSx) applied to summary statistics from the largest multi-ancestry genome-wide association study meta-analysis for CHD to date, including 1.1 million participants from 5 major genetic ancestry groups. Following training and optimization in the Million Veteran Program, we evaluated the best-performing PRSCHD in 176,988 individuals across 9 diverse cohorts.

Results: Multi-ancestry PRSPT and PRSCSx outperformed ancestry-specific PRSPT and PRSCSx across a range of tuning values. Two best-performing multi-ancestry PRSCHD (ie, PRSPTmult and PRSCSxmult) and 1 ancestry-specific (PRSCSxEUR) were taken forward for validation. PRSPTmult demonstrated the strongest association with CHD in individuals of South Asian ancestry and European ancestry (odds ratio per 1 SD [95% CI, 2.75 [2.41-3.14], 1.65 [1.59-1.72]), followed by East Asian ancestry (1.56 [1.50-1.61]), Hispanic/Latino ancestry (1.38 [1.24-1.54]), and African ancestry (1.16 [1.11-1.21]). PRSCSxmult showed the strongest associations in South Asian ancestry (2.67 [2.38-3.00]) and European ancestry (1.65 [1.59-1.71]), lower in East Asian ancestry (1.59 [1.54-1.64]), Hispanic/Latino ancestry (1.51 [1.35-1.69]), and the lowest in African ancestry (1.20 [1.15-1.26]).

Conclusions: The use of summary statistics from a large multi-ancestry genome-wide meta-analysis improved the performance of PRSCHD in most ancestry groups compared with single-ancestry methods. Despite the use of one of the largest and most diverse sets of training and validation cohorts to date, improvement of predictive performance was limited in African ancestry. This highlights the need for larger genome-wide association study datasets of underrepresented populations to enhance the performance of PRSCHD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于祖先多样性全基因组关联研究和特定人群优化的冠心病多祖先多基因风险评分。
背景:多基因风险评分(PRS)的预测性能在不同人群中存在差异。为了便于临床公平使用,我们为 5 个遗传祖先群体开发了冠心病(CHD;PRSCHD)的多基因风险评分:我们基于剪枝和阈值以及连续收缩先验(使用基于祖先的连续收缩方法开发的冠心病多基因风险评分),得出了特定祖先和多祖先的 PRSCHD,并将其应用于迄今为止最大的冠心病多祖先全基因组关联研究荟萃分析的汇总统计中,其中包括来自 5 个主要遗传祖先群体的 110 万参与者。在 "百万退伍军人计划"(Million Veteran Program)中进行培训和优化后,我们在 9 个不同队列的 176 988 人中评估了表现最佳的 PRSCHD:结果:使用剪枝和阈值化方法开发的冠心病多基因风险评分,以及使用基于祖先的连续收缩方法开发的冠心病多基因风险评分,在一系列调整值中,均优于使用剪枝和阈值化方法开发的特定祖先冠心病多基因风险评分,以及使用基于祖先的连续收缩方法开发的冠心病多基因风险评分。两个表现最好的多种系 PRSCHD(即使用剪枝和阈值方法开发的、使用多种系人群优化的冠心病多基因风险评分,以及使用基于种系的连续收缩方法开发的、使用多种系人群优化的冠心病多基因风险评分)和一个特定种系(PRSCSxEUR)被用于验证。使用剪枝和阈值法(PT)开发的冠心病多基因风险评分在多血统人群中进行了优化,结果显示南亚遗传血统和欧洲遗传血统的个体与冠心病的关联性最强(每 1 SD 的几率比 [95% CI, 2.75[2.41-3.14]、1.65[1.59-1.72]),其次是东亚遗传血统(1.56[1.50-1.61])、西班牙/拉丁美洲遗传血统(1.38[1.24-1.54])和非洲遗传血统(1.16[1.11-1.21])。使用基于祖先的连续收缩方法开发的冠心病多基因风险评分在多祖先人群中进行了优化,结果显示,南亚遗传祖先(2.67 [2.38-3.00])和欧洲遗传血统(1.65 [1.59-1.71])的相关性最强,东亚遗传血统(1.59 [1.54-1.64])和西班牙/拉丁美洲遗传血统(1.51 [1.35-1.69])的相关性较低,而非洲遗传血统(1.20 [1.15-1.26])的相关性最低:结论:与单种属方法相比,使用大型多种属全基因组荟萃分析的汇总统计数据提高了 PRSCHD 在大多数种属群体中的性能。尽管使用了迄今为止最大、最多样化的一组训练和验证队列,但在非洲基因血统中,预测性能的提高仍然有限。这突出表明,需要对代表性不足的人群进行更大规模的全基因组关联研究数据集,以提高 PRSCHD 的性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Circulation: Genomic and Precision Medicine
Circulation: Genomic and Precision Medicine Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
9.20
自引率
5.40%
发文量
144
期刊介绍: Circulation: Genomic and Precision Medicine is a distinguished journal dedicated to advancing the frontiers of cardiovascular genomics and precision medicine. It publishes a diverse array of original research articles that delve into the genetic and molecular underpinnings of cardiovascular diseases. The journal's scope is broad, encompassing studies from human subjects to laboratory models, and from in vitro experiments to computational simulations. Circulation: Genomic and Precision Medicine is committed to publishing studies that have direct relevance to human cardiovascular biology and disease, with the ultimate goal of improving patient care and outcomes. The journal serves as a platform for researchers to share their groundbreaking work, fostering collaboration and innovation in the field of cardiovascular genomics and precision medicine.
期刊最新文献
Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes. Yield of Genetic Testing for Long-QT Syndrome in Elderly Patients With Torsades de Pointes. How Normal Is Low-Normal Left Ventricular Ejection Fraction in Familial Dilated Cardiomyopathy? Polygenic Risk and Coronary Artery Disease Severity. Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in KCNQ1, KCNH2, and SCN5A Compared With Patch-Clamp Functional Characterization.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1